SYRE FY 2023 Earnings — Spyre Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SYRESpyre Therapeutics, Inc.

$3B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$886,000-62.0% YoY

Gross Profit

$886,000100.0% margin

Operating Income

-$242M-27348.0% margin

Net Income

-$339M-38238.1% margin

EPS (Diluted)

$-46.15

Cash Flow

Operating Cash Flow

-$100M

Free Cash Flow

-$100M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$342M

Total Liabilities

$158M

Stockholders' Equity

$184M

Cash & Equivalents

$189M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$886,000	$2M	-62.0%
Gross Profit	$886,000	$2M	-62.0%
Operating Income	-$242M	-$85M	-185.8%
Net Income	-$339M	-$84M	-304.2%